M&A Deal Summary

Frutarom Industries Acquires Wiberg

On January 31, 2016, Frutarom Industries acquired food company Wiberg for 130M USD

Acquisition Highlights
  • This is Frutarom Industries’ 37th transaction in the Food sector.
  • This is Frutarom Industries’ largest (disclosed) transaction.
  • This is Frutarom Industries’ 4th transaction in Germany.

M&A Deal Summary

Date 2016-01-31
Target Wiberg
Sector Food
Buyer(s) Frutarom Industries
Deal Type Add-on Acquisition
Deal Value 130M USD

Target

Wiberg

Freilassing, Germany
website
Wiberg GmbH is a provider of food products in germany.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Frutarom Industries

Haifa Bay, Israel

website


Category Company
Founded 1933
Sector Consumer Products
Employees3,100
Revenue 820M ILS (2014)
DESCRIPTION

Frutarom Industries Ltd. is a global company operating in the global flavors and natural fine ingredients markets. Frutarom has significant production and development centers on six continents and markets and sells over 70,000 products to more than 30,000 customers in over 150 countries. Frutarom’s products are intended mainly for the food and beverages, flavor and fragrance extracts, pharmaceutical, nutraceutical, health food, functional food, food additives and cosmetics industries.


DEAL STATS #
Overall 43 of 53
Sector (Food) 37 of 45
Type (Add-on Acquisition) 33 of 42
Country (Germany) 4 of 5
Year (2016) 2 of 6
Size (of disclosed) 1 of 35
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-13 Grow

Ridgefield, New Jersey, United States

Grow Co., Inc. is a manufacturer of food flavors, natural food coloring agents, cosmetic ingredients, and dietary supplements for human and animal consumption.

Buy $20M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-03 Dr. Bruno Stellmach KG

Stadthagen, Germany

Extrakt Chemie is a provider of specialty ingredient extracts, primarily for pharma, natural medications, nutritional supplements, foods and cosmetics. Extrakt Chemie develops, produces and markets specialty solutions of natural extracts, some that include plant-sourced enzymes for use mainly as raw material (API) in the pharmaceutical market, with proven benefits in, among other things, the treatment of liver diseases, digestive problems and the prevention of infections.

Buy $8M